Financhill
Sell
39

USAQ Quote, Financials, Valuation and Earnings

Last price:
$0.6700
Seasonality move :
10.4%
Day range:
$0.6700 - $0.6700
52-week range:
$0.0800 - $1.1361
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.37x
P/B ratio:
--
Volume:
1.3K
Avg. volume:
13.6K
1-year change:
207.62%
Market cap:
$7.6M
Revenue:
$2.1M
EPS (TTM):
-$0.04

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
USAQ
QHSLab, Inc.
-- -- -- -- --
LAB
Standard BioTools, Inc.
$18.5M -$0.03 -54.41% -72.53% $1.55
LNSR
LENSAR, Inc.
$20.5M -$0.09 30.98% -90.51% $15.00
LUDG
Ludwig Enterprises, Inc.
-- -- -- -- --
OPGN
OpGen, Inc.
-- -- -- -- --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
USAQ
QHSLab, Inc.
$0.6700 -- $7.6M -- $0.00 0% 3.37x
LAB
Standard BioTools, Inc.
$1.26 $1.55 $484.6M -- $0.00 0% 3.71x
LNSR
LENSAR, Inc.
$12.08 $15.00 $144.3M -- $0.00 0% 2.42x
LUDG
Ludwig Enterprises, Inc.
$0.0400 -- $6.5M -- $0.00 0% 67,203.89x
OPGN
OpGen, Inc.
$25.5000 -- $256.8M 63.77x $0.00 0% 28.63x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
USAQ
QHSLab, Inc.
162.97% -1.888 73.75% 0.17x
LAB
Standard BioTools, Inc.
6.41% 0.841 5.49% 1.93x
LNSR
LENSAR, Inc.
-31.16% -1.239 1.79% 0.65x
LUDG
Ludwig Enterprises, Inc.
-144.65% -0.654 24.05% 0.00x
OPGN
OpGen, Inc.
16.9% -36,920.421 205167.16% 5.70x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
USAQ
QHSLab, Inc.
$475.6K $96.3K -35.74% -- 13.05% $2.6K
LAB
Standard BioTools, Inc.
$9.5M -$23.5M -22.34% -24.44% -120.02% -$23.1M
LNSR
LENSAR, Inc.
$5.8M -$7.6M -684.94% -1013.45% -52.95% -$3.5M
LUDG
Ludwig Enterprises, Inc.
-- -$371.4K -- -- -419868.12% -$139.1K
OPGN
OpGen, Inc.
-$48.1K -$702.2K 70.06% 89.47% -5625.96% -$333.3K

QHSLab, Inc. vs. Competitors

  • Which has Higher Returns USAQ or LAB?

    Standard BioTools, Inc. has a net margin of 4.53% compared to QHSLab, Inc.'s net margin of -162.05%. QHSLab, Inc.'s return on equity of -- beat Standard BioTools, Inc.'s return on equity of -24.44%.

    Company Gross Margin Earnings Per Share Invested Capital
    USAQ
    QHSLab, Inc.
    64.52% $0.00 $970.2K
    LAB
    Standard BioTools, Inc.
    48.51% -$0.09 $427M
  • What do Analysts Say About USAQ or LAB?

    QHSLab, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.55 which suggests that it could grow by 23.02%. Given that Standard BioTools, Inc. has higher upside potential than QHSLab, Inc., analysts believe Standard BioTools, Inc. is more attractive than QHSLab, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    USAQ
    QHSLab, Inc.
    0 0 0
    LAB
    Standard BioTools, Inc.
    1 2 0
  • Is USAQ or LAB More Risky?

    QHSLab, Inc. has a beta of 0.510, which suggesting that the stock is 48.993% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.290, suggesting its more volatile than the S&P 500 by 28.967%.

  • Which is a Better Dividend Stock USAQ or LAB?

    QHSLab, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QHSLab, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios USAQ or LAB?

    QHSLab, Inc. quarterly revenues are $737.1K, which are smaller than Standard BioTools, Inc. quarterly revenues of $19.6M. QHSLab, Inc.'s net income of $33.4K is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, QHSLab, Inc.'s price-to-earnings ratio is -- while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QHSLab, Inc. is 3.37x versus 3.71x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    USAQ
    QHSLab, Inc.
    3.37x -- $737.1K $33.4K
    LAB
    Standard BioTools, Inc.
    3.71x -- $19.6M -$31.7M
  • Which has Higher Returns USAQ or LNSR?

    LENSAR, Inc. has a net margin of 4.53% compared to QHSLab, Inc.'s net margin of -25.94%. QHSLab, Inc.'s return on equity of -- beat LENSAR, Inc.'s return on equity of -1013.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    USAQ
    QHSLab, Inc.
    64.52% $0.00 $970.2K
    LNSR
    LENSAR, Inc.
    40.56% -$0.31 -$9.2M
  • What do Analysts Say About USAQ or LNSR?

    QHSLab, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 24.17%. Given that LENSAR, Inc. has higher upside potential than QHSLab, Inc., analysts believe LENSAR, Inc. is more attractive than QHSLab, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    USAQ
    QHSLab, Inc.
    0 0 0
    LNSR
    LENSAR, Inc.
    0 2 0
  • Is USAQ or LNSR More Risky?

    QHSLab, Inc. has a beta of 0.510, which suggesting that the stock is 48.993% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.687, suggesting its less volatile than the S&P 500 by 31.253%.

  • Which is a Better Dividend Stock USAQ or LNSR?

    QHSLab, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QHSLab, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios USAQ or LNSR?

    QHSLab, Inc. quarterly revenues are $737.1K, which are smaller than LENSAR, Inc. quarterly revenues of $14.3M. QHSLab, Inc.'s net income of $33.4K is higher than LENSAR, Inc.'s net income of -$3.7M. Notably, QHSLab, Inc.'s price-to-earnings ratio is -- while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QHSLab, Inc. is 3.37x versus 2.42x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    USAQ
    QHSLab, Inc.
    3.37x -- $737.1K $33.4K
    LNSR
    LENSAR, Inc.
    2.42x -- $14.3M -$3.7M
  • Which has Higher Returns USAQ or LUDG?

    Ludwig Enterprises, Inc. has a net margin of 4.53% compared to QHSLab, Inc.'s net margin of -427991.3%. QHSLab, Inc.'s return on equity of -- beat Ludwig Enterprises, Inc.'s return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    USAQ
    QHSLab, Inc.
    64.52% $0.00 $970.2K
    LUDG
    Ludwig Enterprises, Inc.
    -- -- -$1.4M
  • What do Analysts Say About USAQ or LUDG?

    QHSLab, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Ludwig Enterprises, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that QHSLab, Inc. has higher upside potential than Ludwig Enterprises, Inc., analysts believe QHSLab, Inc. is more attractive than Ludwig Enterprises, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    USAQ
    QHSLab, Inc.
    0 0 0
    LUDG
    Ludwig Enterprises, Inc.
    0 0 0
  • Is USAQ or LUDG More Risky?

    QHSLab, Inc. has a beta of 0.510, which suggesting that the stock is 48.993% less volatile than S&P 500. In comparison Ludwig Enterprises, Inc. has a beta of 2.470, suggesting its more volatile than the S&P 500 by 146.979%.

  • Which is a Better Dividend Stock USAQ or LUDG?

    QHSLab, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ludwig Enterprises, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QHSLab, Inc. pays -- of its earnings as a dividend. Ludwig Enterprises, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios USAQ or LUDG?

    QHSLab, Inc. quarterly revenues are $737.1K, which are larger than Ludwig Enterprises, Inc. quarterly revenues of --. QHSLab, Inc.'s net income of $33.4K is higher than Ludwig Enterprises, Inc.'s net income of $31.3K. Notably, QHSLab, Inc.'s price-to-earnings ratio is -- while Ludwig Enterprises, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QHSLab, Inc. is 3.37x versus 67,203.89x for Ludwig Enterprises, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    USAQ
    QHSLab, Inc.
    3.37x -- $737.1K $33.4K
    LUDG
    Ludwig Enterprises, Inc.
    67,203.89x -- -- $31.3K
  • Which has Higher Returns USAQ or OPGN?

    OpGen, Inc. has a net margin of 4.53% compared to QHSLab, Inc.'s net margin of -5629.82%. QHSLab, Inc.'s return on equity of -- beat OpGen, Inc.'s return on equity of 89.47%.

    Company Gross Margin Earnings Per Share Invested Capital
    USAQ
    QHSLab, Inc.
    64.52% $0.00 $970.2K
    OPGN
    OpGen, Inc.
    55.51% -$0.06 $12.2M
  • What do Analysts Say About USAQ or OPGN?

    QHSLab, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand OpGen, Inc. has an analysts' consensus of -- which suggests that it could grow by 17.65%. Given that OpGen, Inc. has higher upside potential than QHSLab, Inc., analysts believe OpGen, Inc. is more attractive than QHSLab, Inc..

    Company Buy Ratings Hold Ratings Sell Ratings
    USAQ
    QHSLab, Inc.
    0 0 0
    OPGN
    OpGen, Inc.
    0 0 0
  • Is USAQ or OPGN More Risky?

    QHSLab, Inc. has a beta of 0.510, which suggesting that the stock is 48.993% less volatile than S&P 500. In comparison OpGen, Inc. has a beta of -3,423.037, suggesting its less volatile than the S&P 500 by 342403.692%.

  • Which is a Better Dividend Stock USAQ or OPGN?

    QHSLab, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OpGen, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QHSLab, Inc. pays -- of its earnings as a dividend. OpGen, Inc. pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios USAQ or OPGN?

    QHSLab, Inc. quarterly revenues are $737.1K, which are larger than OpGen, Inc. quarterly revenues of --. QHSLab, Inc.'s net income of $33.4K is higher than OpGen, Inc.'s net income of -$608.7K. Notably, QHSLab, Inc.'s price-to-earnings ratio is -- while OpGen, Inc.'s PE ratio is 63.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QHSLab, Inc. is 3.37x versus 28.63x for OpGen, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    USAQ
    QHSLab, Inc.
    3.37x -- $737.1K $33.4K
    OPGN
    OpGen, Inc.
    28.63x 63.77x -- -$608.7K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 7

Bill Holdings, Inc. [BILL] is up 37.11% over the past day.

Buy
75
PRLB alert for Feb 7

Proto Labs, Inc. [PRLB] is up 28.33% over the past day.

Sell
30
MSTR alert for Feb 7

Strategy, Inc. [MSTR] is up 26.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock